Mathieu Bakhoum Lab
Bridging ophthalmology and cancer research
Uveal melanoma
We strive to understand the drivers of uveal melanoma metastasis, and develop novel therapeutic targets.
Retinal biomarkers of cardiovasuclar disease
We idenitified RIPLs, which are biomarkers to detect underlying cardiovascular disease.
In the News
News and Media coverage of our work.
* Demkowicz PC et al. Determinants of Overall Survival in Patients with Metastatic Uveal Melanoma. Cancer (2023)
* Bakhoum MF et al. Loss of Polycomb Repressive Complex 1 activity and chromosomal instability drive uveal melanoma progression. Nature Communications (2021).
* Long C et al. Prevalence of subclinical retinal ischemia in cardiovascular disease - a hypothesis driven study. EClinical Medicine (2021).
* Miguez S et al. Validation of the Prognostic Usefulness of the Gene Expression Profiling Test in Patients with Uveal Melanoma. Ophthalmology (2023).
Funding Sources
